Candida parapsilosis and the neonate: epidemiology, virulence and host defense in a unique patient setting
暂无分享,去创建一个
[1] D. Kaufman,et al. Changing Incidence of Candida Bloodstream Infections Among NICU Patients in the United States: 1995–2004 , 2006, Pediatrics.
[2] David W Williams,et al. Adherence and biofilm formation of non-Candida albicans Candida species. , 2011, Trends in microbiology.
[3] R. Faix. Invasive neonatal candidiasis: comparison of albicans and parapsilosis infection. , 1992, The Pediatric infectious disease journal.
[4] D. Kaufman,et al. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. , 2001, The New England journal of medicine.
[5] P. Smith,et al. The use of antifungal therapy in neonatal intensive care. , 2012, Clinics in perinatology.
[6] G. Quindós,et al. In vitro activities of natural products against oral Candida isolates from denture wearers , 2011, BMC complementary and alternative medicine.
[7] G. Butler,et al. Phenotype switching affects biofilm formation by Candida parapsilosis. , 2005, Microbiology.
[8] J. Sobel,et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] M. Pfaller,et al. Use of Epidemiological Cutoff Values To Examine 9-Year Trends in Susceptibility of Candida Species to Anidulafungin, Caspofungin, and Micafungin , 2010, Journal of Clinical Microbiology.
[10] S. Filler,et al. Als3 Is a Candida albicans Invasin That Binds to Cadherins and Induces Endocytosis by Host Cells , 2007, PLoS biology.
[11] L. Saiman,et al. Risk factors for candidemia in Neonatal Intensive Care Unit patients , 2000, The Pediatric infectious disease journal.
[12] L. Saiman,et al. Epidemiology of Candidemia at a Children's Hospital, 2002 to 2006 , 2009, The Pediatric infectious disease journal.
[13] P. Mann,et al. Impact of Antifungal Prophylaxis on Colonization and Azole Susceptibility of Candida Species , 2009, Antimicrobial Agents and Chemotherapy.
[14] E. Beltrão,et al. Adherence of Candida albicans and Candida parapsilosis to epithelial cells correlates with fungal cell surface carbohydrates , 2011, Mycoses.
[15] David W Williams,et al. Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition. , 2009, Medical mycology.
[16] K. Yuen,et al. Antifungal Susceptibility and Virulence Attributes of Bloodstream Isolates of Candida from Hong Kong and Finland , 2011, Mycopathologia.
[17] S. Simmens,et al. Incidence of Candida parapsilosis colonization in an intensive care nursery population and its association with invasive fungal disease , 1994, The Pediatric infectious disease journal.
[18] A. Gácser,et al. The Stearoyl-Coenzyme A Desaturase 1 Is Essential for Virulence and Membrane Stress in Candida parapsilosis through Unsaturated Fatty Acid Production , 2010, Infection and Immunity.
[19] M. Rouabhia,et al. Normal Human Gingival Epithelial Cells Sense C. parapsilosis by Toll-Like Receptors and Module Its Pathogenesis through Antimicrobial Peptides and Proinflammatory Cytokines , 2010, Mediators of inflammation.
[20] D. Wildemeersch,et al. Number of sites of perinatal Candida colonization and neutropenia are associated with nosocomial candidemia in the neonatal intensive care unit patient , 2010, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[21] R. Ryan,et al. Vertical and Horizontal Transmission of Candida albicans in Very Low Birth Weight Infants Using DNA Fingerprinting Techniques , 2008, The Pediatric infectious disease journal.
[22] S. Challacombe,et al. A Biphasic Innate Immune MAPK Response Discriminates between the Yeast and Hyphal Forms of Candida albicans in Epithelial Cells , 2010, Cell host & microbe.
[23] G. González,et al. Trends in Species Distribution and Susceptibility of Bloodstream Isolates of Candida Collected in Monterrey, Mexico, to Seven Antifungal Agents: Results of a 3-Year (2004 to 2007) Surveillance Study , 2008, Journal of Clinical Microbiology.
[24] P. Taylor,et al. Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection , 2009, The Journal of experimental medicine.
[25] N. Prasadarao,et al. Mechanisms of Candida albicans Trafficking to the Brain , 2011, PLoS pathogens.
[26] Deepak Kumar,et al. Dexamethasone Therapy and Candida Sepsis in Neonates Less Than 1250 Grams , 2002, Journal of Perinatology.
[27] D. Stevens,et al. Candida parapsilosis fungemia in neonates: genotyping results suggest healthcare workers hands as source, and review of published studies , 2007, Mycopathologia.
[28] N. Cerikcioglu,et al. Acid proteinase, phospholipase, and biofilm production of Candida species isolated from blood cultures , 2007, Mycopathologia.
[29] M. Yalaz,et al. Successful caspofungin treatment of multidrug resistant Candida parapsilosis septicaemia in an extremely low birth weight neonate , 2006, Mycoses.
[30] T. Kuijpers,et al. Complement Receptor 3 and Toll-Like Receptor 4 Act Sequentially in Uptake and Intracellular Killing of Unopsonized Salmonella enterica Serovar Typhimurium by Human Neutrophils , 2007, Infection and Immunity.
[31] A. Chakrabarti,et al. Candida colonization and candidemia in a pediatric intensive care unit , 2008, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[32] J. Laurini,et al. Neonatal Candida parapsilosis meningitis and empyema related to epidural migration of a central venous catheter , 2008, Clinical Neurology and Neurosurgery.
[33] M. Maiden,et al. Candida orthopsilosis and Candida metapsilosis spp. nov. To Replace Candida parapsilosis Groups II and III , 2005, Journal of Clinical Microbiology.
[34] S. Fridkin,et al. Determining Risk Factors for Candidemia Among Newborn Infants From Population-Based Surveillance: Baltimore, Maryland, 1998–2000 , 2005, The Pediatric infectious disease journal.
[35] M. Netea,et al. Innate immune mechanisms for recognition and uptake of Candida species. , 2010, Trends in immunology.
[36] W. Göpel,et al. Galectin‐3 in cord blood of term and preterm infants , 2012, Clinical and experimental immunology.
[37] A. Gácser,et al. Targeted gene deletion in Candida parapsilosis demonstrates the role of secreted lipase in virulence. , 2007, The Journal of clinical investigation.
[38] M. Ghannoum,et al. Comparison of Biofilms Formed by Candidaalbicans and Candidaparapsilosis on Bioprosthetic Surfaces , 2002, Infection and Immunity.
[39] S. Akira,et al. Dectin-2 recognition of alpha-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans. , 2010, Immunity.
[40] S. Filler,et al. Host Cell Invasion and Virulence Mediated by Candida albicans Ssa1 , 2010, PLoS pathogens.
[41] David W Williams,et al. Characterization of Candida parapsilosis infection of an in vitro reconstituted human oral epithelium. , 2009, European journal of oral sciences.
[42] J. Vazquez,et al. Multiechinocandin- and Multiazole-Resistant Candida parapsilosis Isolates Serially Obtained during Therapy for Prosthetic Valve Endocarditis , 2005, Antimicrobial Agents and Chemotherapy.
[43] U. Dilmen,et al. Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants , 2010, Archives of Disease in Childhood: Fetal and Neonatal Edition.
[44] D. Soll,et al. Emergence of Fluconazole Resistance in a Candida parapsilosis Strain That Caused Infections in a Neonatal Intensive Care Unit , 2005, Journal of Clinical Microbiology.
[45] B. Yoder,et al. RESISTANT CANDIDA PARAPSILOSIS ASSOCIATED WITH LONG TERM FLUCONAZOLE PROPHYLAXIS IN AN ANIMAL MODEL , 2004, The Pediatric infectious disease journal.
[46] Joseph M. Campos,et al. Antifungal susceptibility of Candida spp. isolated from pediatric patients: a survey of 4 children's hospitals. , 2005, Diagnostic microbiology and infectious disease.
[47] G. De Domenico,et al. Ambroxol influences voriconazole resistance of Candida parapsilosis biofilm. , 2012, FEMS yeast research.
[48] Y. Chou,et al. Association of fungal colonization and invasive disease in very low birth weight infants. , 1998, The Pediatric infectious disease journal.
[49] Alistair J. P. Brown,et al. Immune Recognition of Candida albicans β-glucan by Dectin-1 , 2007 .
[50] M. Pfaller,et al. In Vitro Susceptibility of Invasive Isolates of Candida spp. to Anidulafungin, Caspofungin, and Micafungin: Six Years of Global Surveillance , 2007, Journal of Clinical Microbiology.
[51] T. Walsh,et al. Empirical therapy for neonatal candidemia in very low birth weight infants. , 2003, Pediatrics.
[52] W. McGuire,et al. Candida parapsilosis infection in very low birthweight infants , 2007, Archives of Disease in Childhood - Fetal and Neonatal Edition.
[53] V. Anttila,et al. Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007 , 2010, BMC infectious diseases.
[54] Y. Chou,et al. Candidaemia in special care nurseries: comparison of albicans and parapsilosis infection. , 2000, The Journal of infection.
[55] M. Maccani,et al. High efficiency opsonin-independent phagocytosis of Candida parapsilosis by human neutrophils. , 2010, Medical mycology.
[56] M. Cuenca‐Estrella,et al. Prevalence and Susceptibility Profile of Candida metapsilosis and Candida orthopsilosis: Results from Population-Based Surveillance of Candidemia in Spain , 2008, Antimicrobial Agents and Chemotherapy.
[57] T. Metsvaht,et al. Risk factors associated with gut and nasopharyngeal colonization by common Gram-negative species and yeasts in neonatal intensive care units patients. , 2011, Early human development.
[58] T. Kuijpers,et al. Complement receptor 3, not Dectin-1, is the major receptor on human neutrophils for beta-glucan-bearing particles. , 2009, Molecular immunology.
[59] A. Cassone,et al. Vaginopathic and proteolytic Candida species in outpatients attending a gynaecology clinic. , 1991, Journal of clinical pathology.
[60] M. Yamazaki,et al. Comparison of proteinase, lipase and alpha-glucosidase activities from the clinical isolates of Candida species. , 2006, Japanese journal of infectious diseases.
[61] D. Palazzi,et al. Candida Non-albicans Versus Candida Albicans Fungemia in the Non-neonatal Pediatric Population , 2011, The Pediatric infectious disease journal.
[62] M. Netea,et al. Differential IL-17 Production and Mannan Recognition Contribute to Fungal Pathogenicity and Commensalism , 2010, The Journal of Immunology.
[63] A. Gácser,et al. A Rat Model of Neonatal Candidiasis Demonstrates the Importance of Lipases as Virulence Factors for Candida albicans and Candida parapsilosis , 2011, Mycopathologia.
[64] M. Falagas,et al. Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review. , 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[65] Choukri Ben Mamoun,et al. Amino acids mediate colony and cell differentiation in the fungal pathogen Candida parapsilosis. , 2006, Microbiology.
[66] Y. Carmeli,et al. Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[67] M. Maule,et al. Routine Use of Fluconazole Prophylaxis in a Neonatal Intensive Care Unit Does Not Select Natively Fluconazole-Resistant Candida Subspecies , 2008, The Pediatric infectious disease journal.
[68] S. Lockhart,et al. Geographic Distribution and Antifungal Susceptibility of the Newly Described Species Candida orthopsilosis and Candida metapsilosis in Comparison to the Closely Related Species Candida parapsilosis , 2008, Journal of Clinical Microbiology.
[69] Trees Jansen,et al. Immune recognition of Candida albicans beta-glucan by dectin-1. , 2007, The Journal of infectious diseases.
[70] M. Pires,et al. Yeasts isolated from blood and catheter in children from a Public Hospital of São Paulo, Brazil , 2004, Mycopathologia.
[71] A. Mitchell,et al. How to build a biofilm: a fungal perspective. , 2006, Current opinion in microbiology.
[72] N. Prasadarao,et al. N-cadherin Mediates Endocytosis of Candida albicans by Endothelial Cells* , 2005, Journal of Biological Chemistry.
[73] M. Simitsopoulou,et al. Additive antifungal activity of anidulafungin and human neutrophils against Candida parapsilosis biofilms. , 2011, The Journal of antimicrobial chemotherapy.
[74] L. Tomáška,et al. Biology and genetics of the pathogenic yeast Candida parapsilosis , 2009, Current Genetics.
[75] R. Auten,et al. When to Suspect Fungal Infection in Neonates: A Clinical Comparison of Candida albicans and Candida parapsilosis Fungemia With Coagulase-Negative Staphylococcal Bacteremia , 2000, Pediatrics.
[76] R. Hernández-Castro,et al. Outbreak of Candida parapsilosis in a neonatal intensive care unit: a health care workers source , 2010, European Journal of Pediatrics.
[77] N. Cerikcioglu,et al. Acid proteinase, phospholipase and adherence properties of Candida parapsilosis strains isolated from clinical specimens of hospitalised patients , 2005, Mycoses.
[78] A. Gácser,et al. Candida parapsilosis, an Emerging Fungal Pathogen , 2008, Clinical Microbiology Reviews.
[79] T. Walsh,et al. Caspofungin Therapy of Neonates With Invasive Candidiasis , 2004, The Pediatric infectious disease journal.
[80] T. Mayadas,et al. The β-glucan receptor Dectin-1 activates the integrin Mac-1 in neutrophils via Vav protein signaling to promote Candida albicans clearance. , 2011, Cell host & microbe.
[81] N. Jain,et al. Epidemiology of Candidemia in a Tertiary Care Centre of North India: 5-Year Study , 2007, Infection.
[82] M. Ghannoum,et al. Differential in vitro activity of anidulafungin, caspofungin and micafungin against Candida parapsilosis isolates recovered from a burn unit. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[83] C. Vágvölgyi,et al. In vitro interactions of Candida parapsilosis wild type and lipase deficient mutants with human monocyte derived dendritic cells , 2011, BMC Microbiology.
[84] S. G. Monteiro,et al. In vitro differential activity of phospholipases and acid proteinases of clinical isolates of Candida. , 2011, Revista da Sociedade Brasileira de Medicina Tropical.
[85] L. Su,et al. Genotyping analysis of colonizing candidal isolates from very-low-birthweight infants in a neonatal intensive care unit. , 2004, The Journal of hospital infection.
[86] J. Sizun,et al. Low rate of Candida parapsilosis-related colonization and infection in hospitalized preterm infants: a one-year prospective study. , 2001, The Journal of hospital infection.
[87] William Oh,et al. Neonatal Candidiasis Among Extremely Low Birth Weight Infants: Risk Factors, Mortality Rates, and Neurodevelopmental Outcomes at 18 to 22 Months , 2006, Pediatrics.
[88] W. McGuire,et al. Invasive fungal infection in very low birthweight infants: national prospective surveillance study , 2005, Archives of Disease in Childhood - Fetal and Neonatal Edition.
[89] A. Cassone,et al. Biotyping and Virulence Properties of Skin Isolates ofCandida parapsilosis , 1999, Journal of Clinical Microbiology.
[90] J. Nosanchuk,et al. Virulence of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis in reconstituted human tissue models. , 2007, Fungal genetics and biology : FG & B.
[91] A. Gácser,et al. Candida parapsilosis fat storage-inducing transmembrane (FIT) protein 2 regulates lipid droplet formation and impacts virulence. , 2011, Microbes and infection.
[92] J. Nosanchuk,et al. Fatty Acid Synthase Impacts the Pathobiology of Candida parapsilosis In Vitro and during Mammalian Infection , 2009, PloS one.
[93] G. Fadda,et al. Biofilm Production by Candida Species and Inadequate Antifungal Therapy as Predictors of Mortality for Patients with Candidemia , 2007, Journal of Clinical Microbiology.
[94] P. Horváth,et al. The identification of gene duplication and the role of secreted aspartyl proteinase 1 in Candida parapsilosis virulence. , 2012, The Journal of infectious diseases.
[95] D. Stevens,et al. Candida parapsilosis: a review of its epidemiology, pathogenesis, clinical aspects, typing and antimicrobial susceptibility , 2009, Critical reviews in microbiology.
[96] David L. Williams,et al. Dectin‐1 promotes fungicidal activity of human neutrophils , 2007, European journal of immunology.
[97] Ken Jacobson,et al. A Novel Pseudopodial Component of the Dendritic Cell Anti-Fungal Response: The Fungipod , 2010, PLoS pathogens.
[98] W. McGuire,et al. Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants. , 2007, The Cochrane database of systematic reviews.
[99] Ronald N. Jones,et al. Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008-2009). , 2010, Diagnostic microbiology and infectious disease.
[100] P. Ricciardi-Castagnoli,et al. Dendritic Cells Discriminate between Yeasts and Hyphae of the Fungus Candida albicans , 2000, The Journal of experimental medicine.
[101] E. Badran,et al. Epidemiological characteristics of Candida species colonizing oral and rectal sites of Jordanian infants , 2011, BMC pediatrics.
[102] D. Moyes,et al. Activation of MAPK/c-Fos induced responses in oral epithelial cells is specific to Candida albicans and Candida dubliniensis hyphae , 2011, Medical Microbiology and Immunology.
[103] I. Pichová,et al. Two aspartic proteinases secreted by the pathogenic yeast Candida parapsilosis differ in expression pattern and catalytic properties , 2009, Biological chemistry.
[104] M. C. Furlaneto,et al. Haemolytic and proteinase activities in clinical isolates of Candida parapsilosis and Candida tropicalis with reference to the isolation anatomic site , 2011, Mycoses.
[105] J. Nosanchuk,et al. Lipid droplet formation protects against gluco/lipotoxicity in Candida parapsilosis: An essential role of fatty acid desaturase Ole1 , 2011, Cell cycle.
[106] J. Bliss,et al. Oxidative burst and phagocytosis of neonatal neutrophils confronting Candida albicans and Candida parapsilosis. , 2009, Early human development.
[107] L. Rubin,et al. Emergence of Candida parapsilosis as the predominant species causing candidemia in children. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[108] Benjamin J Park,et al. Candidemia in Neonatal Intensive Care Units: Barcelona, Spain , 2006, The Pediatric infectious disease journal.